Your Allergies Are Severe, and Your Genes Explain Why.

HLA-DQ2 is a gene that codes for a protein on the surface of your immune cells responsible for showing other immune cells what foreign proteins look like. Think of it as the intelligence briefing system of your immune system, displaying potential threats to your T-cells and B-cells so they can decide whether to mount a response.

When you carry the HLA-DQ2 variant, carried by roughly 25 to 30 percent of people of European ancestry, your immune system is primed to recognize certain allergens as dangerous even when they’re harmless. This doesn’t just apply to food allergens, it influences how your immune system perceives environmental allergens too. Your antigen presentation machinery is biased toward activating Th2 cells, the immune subset that drives allergic reactions.

What this means day-to-day is that your immune system is more likely to say yes to mounting an allergic response when it encounters a trigger. Your mast cells degranulate more readily, your B-cells produce more IgE antibodies, and your airways become inflamed faster. You’re not being weak or overreacting, you’re following a genetic script that predisposes your immune system to allergic pathways.

Interleukin-13 (IL-13) is a Th2 cytokine, a chemical messenger that tells airway cells to ramp up mucus production and recruit eosinophils (a type of immune cell that amplifies inflammation). In a normal allergic response, IL-13 briefly increases, your airways make a little extra mucus to trap allergens, and then it subsides. With certain IL-13 variants, you’re stuck producing elevated IL-13 for longer.

Approximately 30 to 35 percent of people carry variants that increase IL-13 expression, and when you do, your airways respond to allergen exposure by producing far more mucus and becoming more hyperresponsive than average. This is what causes that relentless postnasal drip, the sensation that your throat is always clogged, and the difficulty breathing that antihistamines don’t touch.

What this feels like is a low-grade asthmatic response even when you don’t have true asthma. You get congested easily, you produce thick mucus that won’t clear, and your airways feel tight. Your lungs are more reactive than the baseline, which is why you might cough after exercise or exposure to cold air when others don’t.

Interleukin-4 (IL-4) is the master cytokine that tells your B-cells to produce IgE antibodies instead of IgG antibodies. IgE is the antibody class that triggers mast cell degranulation and immediate allergic reactions. In people without variants, IL-4 levels rise briefly during true immune threats, B-cells make some IgE, and then the response resolves. But if you carry an IL-4 variant, your baseline IL-4 is elevated.

The IL-4 C-590T variant, present in roughly 30 percent of the population, skews your entire immune system toward Th2 responses, meaning your B-cells are more likely to produce IgE antibodies against allergens that shouldn’t trigger them in the first place. This is why you might test positive for allergies to things that never bothered you before, or why you develop new allergies as you age.

What this means practically is that you’re more likely to become sensitized to new allergens, your allergic responses are more intense, and you probably have a higher baseline of circulating IgE antibodies. You might notice that you react strongly to environmental changes, that you develop food allergies seemingly out of nowhere, or that your allergy season symptoms are disproportionate compared to the pollen count.

Toll-like receptor 4 (TLR4) is a pattern recognition receptor on immune cells that detects bacterial lipopolysaccharides (LPS). When your immune system recognizes LPS, it mounts an innate immune response that trains your immune system to distinguish harmless bacteria from truly dangerous ones. This early exposure and training is how children develop tolerance to environmental bacteria and develop balanced immune responses.

The TLR4 D299G variant, found in approximately 10 percent of people of European ancestry, reduces your immune system’s ability to sense bacterial LPS, which means your innate immune training is incomplete. Without proper early immune training, your adaptive immune system skews toward Th2 responses and allergic pathways instead of balanced immunity.

What this means is that you’re more likely to have allergies because your immune system never learned to distinguish harmless environmental proteins from true threats. You probably developed your first allergies earlier than average, and you’re more susceptible to picking up new allergies throughout your life. You might also notice that you get infections more easily, because your TLR4 isn’t properly recognizing and responding to bacterial presence.

FUT2 is a gene that codes for an enzyme controlling which sugars coat your intestinal cells. These coatings determine which bacteria can colonize your gut. If you have a functional FUT2, your intestinal cells display diverse sugars, and your microbiome includes many different bacterial species. If you carry the FUT2 loss-of-function variant, your intestinal cells display fewer sugar types, and your microbiome is less diverse.

Approximately 40 to 50 percent of the population carries at least one FUT2 loss-of-function allele, and when you do, your gut microbiome is less diverse, which means your intestinal bacteria can’t properly train your immune system to tolerate harmless antigens. This results in an immune system that’s more reactive and more likely to mount allergic responses.

What this feels like is allergies that seemed to develop or worsen after you took antibiotics, or allergies that improved when you deliberately tried to increase microbial diversity. You might notice that your immune system is generally more reactive, you catch colds easily, and you have food sensitivities alongside environmental allergies.

The vitamin D receptor (VDR) is a nuclear receptor that activates the genes responsible for immune tolerance. When you have functional VDR and adequate vitamin D, your immune system can transition from Th1 (antiviral) and Th2 (allergic) responses into Th3 (tolerogenic) responses. This switch is critical for preventing chronic immune activation. Without proper VDR signaling, your immune system stays stuck in reactive mode.

VDR has several functional variants, including FokI (rs2228570), and people carrying certain combinations have reduced ability to activate tolerogenic genes even when vitamin D levels are adequate. Roughly 40 to 50 percent of people have VDR variants that reduce this tolerance-promoting function. This means your immune system is biologically less capable of switching off its allergic response, even with behavioral interventions.

What this means day-to-day is that your allergies don’t resolve as quickly as other people’s do. Your immune system gets activated by an allergen exposure and stays activated. You might notice that antihistamines help temporarily but your symptoms return when the medication wears off, or that your allergies are worse during winter months when vitamin D is lower.